pharmaphorum7 年
Sobi drug gains NICE approval after 4 year wait
NICE originally rejected Xiapex (collagenase clostridium histolyticum) from Swedish Orphan Biovitrum (SOBI) back in 2013, the first pharmacological treatment for Dupuytren’s contracture.